SCHEMBL24973034

SCHEMBL24973034

CSS[C@@H](C)OC1C[C@H](n2nc(C#CCNC(=O)C(F)(F)F)c3c(=O)[nH]c(/N=C\N(C)C)nc32)O[C@@H]1CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25754178 1.00 — —
SCHEMBL25754182 1.00 — —
SCHEMBL24973031 1.00 — —
SCHEMBL22598548 0.88 KDM4E (0.33) —
SCHEMBL22618373 0.88 KDM4E (0.33) —
SCHEMBL22327256 0.88 KDM4E (0.33) —
SCHEMBL22327323 0.88 KDM4E (0.33) —
SCHEMBL24973040 0.88 — —
SCHEMBL24973030 0.88 — —
SCHEMBL25754186 0.88 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230203083-A1 NUCLEOTIDE ANALOGUES FIRST-CITIZENS BANK & TRUST COMPANY 2023-06-29 — — US disclosed
US-20230028359-A1 NUCLEOTIDE ANALOGUES FIRST-CITIZENS BANK & TRUST COMPANY 2023-01-26 — — US disclosed
Send feedback